Navigation Links
ThromboGenics NV: Business Update
Date:5/14/2009

LEUVEN, Belgium, May 14 /PRNewswire-FirstCall/ --

- Regulated Information

- Disclosure in Accordance With the Law of May 2, 2007

ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, is today issuing a business update for the three month period ending 31 March, 2009.

Patrik De Haes, CEO of ThromboGenics, commenting on today's announcement, said: "ThromboGenics has had an excellent start to 2009 as we continue to build on the significant progress made in 2008. Patient recruitment in the Phase III development program of our lead product microplasmin for back of the eye disease is on track, and we believe that this exciting product will allow us to build our own ophthalmology franchise over time. We have also continued to make considerable progress with our other key clinical and pre-clinical programs. We have begun a Phase II trial for our novel long-acting anticoagulant TB-402 and also received the first milestone from our strategic agreement with Roche for the novel anti-cancer agent TB-403. The development of Anti-VPAC, our pre-clinical candidate for the treatment of thrombocytopenia, received a major boost when we were awarded a EUR3.2 million grant from the IWT.

"I am confident that ThromboGenics will continue to generate significant shareholder value throughout the remainder of 2009 as we continue to maximize the value of our exciting product pipeline."

    Financial Update

    - ThromboGenics achieved revenues of EUR3.3 million in 1st
      Quarter 2009. Most of this income came from the EUR3 million technology
      transfer success fee from Roche received under the terms of the
      strategic alliance for the novel anti-cancer antibody, TB-403.
      Operating expenses were EUR4.3 million during this three month period,

'/>"/>
SOURCE ThromboGenics NV
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007
2. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
3. ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402
4. ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell
5. ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
6. ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting
7. ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer
8. ThromboGenics Announces 2007 Full Year Results
9. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
10. ThromboGenics N.V. - Business Update
11. ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Boston, MA (PRWEB) May 28, 2015 ... and director, James L. Sherley, M.D., Ph.D., will present ... cell medicine. In a conference talk, he will ... stem cell culture designs with computer simulation to produce ... stem cell number and quality over time in culture. ...
(Date:5/27/2015)... Mass. , May 27, 2015 ... biotechnology company focused on discovering and developing innovative ... ophthalmology, today announced that it has commenced a public ... to purchase shares of its common stock and ... common stock. The shares of common stock, warrants ...
(Date:5/27/2015)... May 27, 2015 The Academy of Model ... in celebrating National Model Aviation Day. The third annual celebration ... created to celebrate the model aviation hobby nation-wide and to ... of its approximately 2,350 chartered clubs to celebrate the hobby ... in their communities. There will also be a local event ...
(Date:5/27/2015)... 27, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) today ... 2015. Aviv Boim , CEO ... work to generate functional specific antibodies, targeting identified cancer ... are encouraged by the development progress. We are excited ... which modulate immune checkpoints gain clinical acceptance for cancer ...
Breaking Biology Technology:Asymmetrex Will Discuss the Importance of Adult Tissue Stem Cell Time with 3D Tissue Engineers at the 14th Annual World Preclinical Congress in Boston in June 2Asymmetrex Will Discuss the Importance of Adult Tissue Stem Cell Time with 3D Tissue Engineers at the 14th Annual World Preclinical Congress in Boston in June 3RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 3Academy of Model Aeronautics Foundation to host National Model Aviation Day Motorcycle Rally and Family Fest in Muncie, IN 2Academy of Model Aeronautics Foundation to host National Model Aviation Day Motorcycle Rally and Family Fest in Muncie, IN 3Tikcro Technologies Reports First Quarter 2015 Results 2Tikcro Technologies Reports First Quarter 2015 Results 3
... EXTON, Pa., Oct. 27 BioTrends Research Group, ... results from 204 Nephrologists and 201 Renal Dietitians ... part of the management of dialysis,patients, particularly in ... Active Vitamin D, and Calcimimetic agents., In ...
... Research Group, Inc. was,named one of the 2007 ... by the Philadelphia 100(R), a joint project of ... of,Greater Philadelphia, and the Philadelphia Business Journal. The ... recognition is a testament to the uniqueness of ...
... call today at 4:30 p.m. ET -, SOUTH ... MGRM ) today reported financial results for the,quarter ... of $16.1 million for the third quarter of,2008, 55% ... 2007. This,growth was driven by revenue from Trofile(TM) for ...
Cached Biology Technology:BioTrends Releases TreatmentTrends(TM): Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases TreatmentTrends(TM): Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Monogram Announces 2008 Third Quarter Financial Results 2Monogram Announces 2008 Third Quarter Financial Results 3Monogram Announces 2008 Third Quarter Financial Results 4Monogram Announces 2008 Third Quarter Financial Results 5Monogram Announces 2008 Third Quarter Financial Results 6Monogram Announces 2008 Third Quarter Financial Results 7Monogram Announces 2008 Third Quarter Financial Results 8Monogram Announces 2008 Third Quarter Financial Results 9Monogram Announces 2008 Third Quarter Financial Results 10Monogram Announces 2008 Third Quarter Financial Results 11Monogram Announces 2008 Third Quarter Financial Results 12Monogram Announces 2008 Third Quarter Financial Results 13Monogram Announces 2008 Third Quarter Financial Results 14Monogram Announces 2008 Third Quarter Financial Results 15
(Date:5/6/2015)... Israel , May 6, 2015 LifeBEAM, ... most established helmet producer, announced today that they will ... Helmet, the world,s first bio-sensing cycling helmet and the ... released in two new colors in order to give ... the product. In addition, LifeBEAM and Lazer announced their ...
(Date:4/21/2015)... April 21, 2015 High ... policies are boosting access control systems market in ... to a recently published report by TechSci Research " ... the access control systems market in Saudi ... by 2020.The access control systems market in the Kingdom ...
(Date:4/14/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... New York Design Awards under the category  ,Product Design ... Design Awards are part of a global multi-disciplinary awards ... from the marketplace, industry and judging panel. Winners will ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... DCEvolution, climate change, stem cell researchScientists are frequently ... button issues that pervade the daily news headlines, ... bright lights of the television studio or leading ... from the American Institute of Biological Sciences (AIBS), ...
... College Park, MD, February 11, 2008 -- The American Institute ... Writing Awards today. The winners -- a scientist, a journalist, ... receive a prize of $3,000, an engraved Windsor chair, and ... pieces: , , Tim Folger won the 2007 AIP Science ...
... new thesis from he Swedish medical university Karolinska Institutet ... and women. The scientists who conducted the study think ... depression and chronic anxiety are more common in women ... neurotransmitter that is critical to the development and treatment ...
Cached Biology News:Priming scientists for successful media interviews 2Quantum weirdness, parallel worlds, dinosaur poop, and the ultimate fate of the universe... 2Quantum weirdness, parallel worlds, dinosaur poop, and the ultimate fate of the universe... 3Quantum weirdness, parallel worlds, dinosaur poop, and the ultimate fate of the universe... 4
Mouse monoclonal antibody raised against a partial recombinant CRKRS. NCBI Entrez Gene ID = CRKRS...
... PhosFlow Perm/Wash Buffer I can be used ... proteins to permeabilize cells and to serve ... buffer. Because saponin-mediated cell permeabilization is a ... the cells in the presence of saponin ...
Mouse polyclonal antibody raised against a partial recombinant PREB. NCBI Entrez Gene ID = 10113...
Mouse monoclonal antibody raised against a partial recombinant ACTN4. NCBI Entrez Gene ID = ACTN4...
Biology Products: